Medsafe Orders Recall of Erectile Dysfunction Drugs

Due to a severe risk to health, the recall of four erectile dysfunction or sexual enhancement products has been ordered by Medsafe. Specifically, the Company has asked for recalling products like So Hard for Men, Pulse8 for Women, The Rock and Tonic 66, as they contain undeclared prescription medicines, reported Government's medicines regulator.

These undeclared prescription medicines include tadalafil, sildenafil, and hydroxyhomosildenafil. These drugs have been declared unsafe due to the fact that they can interfere with many heart medications, thus being fatal for one’s medical conditions. The first two medicines are used in dysfunction medicine Cialis and Viagra, respectively.

Therefore, the customers have been advised by Acting Director-General of Health, Andrew Bridgman not to use these products that may make one prone to serious health risks. Also, those patients who have already used them and are now not feeling well, must consult their doctors without further delay.

Mr. Bridgman added, “Consumers should immediately stop taking these products and seek medical advice if they have felt unwell when taking any of these products or if they are also taking other medicines”.

The retailers and distributors have also been ordered not to sell these products that are usually used to improve sexual performance or for the treatment of erectile dysfunction.

Latest News

WSJ: Google Will Unveil Android 5.0 on Multiple Nexus-Branded Smartphones
GM to discontinue Facebook ads due to low consumer impact
Facebook will raise stock price, could be first U.S. company worth $100 billion
Scott Thompson Resigns as CEO of Yahoo
Apple co-founder Steve Wozniak: "I would invest in Facebook”
Apple accuses Samsung of "spoilation of evidence"
Verizon to use Ciena switching technology for expanding its fiber-optic network
Microsoft accused of withholding APIs necessary to build a competitive browser f
Facebook to open App Center in few weeks; developers being asked to prepare apps
Facebook announces App Center
Facebook’s IPO road show got off to a “rough start”
Google Moves For Mistrial In Oracle Case